- Ultra-thinly traded nano cap ESSA Pharma (EPIX -17.2%) is down on more than a 12x surge in volume, albeit on turnover of only 87K shares, following the closing of its all-stock acquisition of Realm Therapeutics plc (NASDAQ:RLM), first announced in May.
- Under the terms of the deal, Realm shareholders received 0.0576359 of an ESSA share for each Realm share owned (or 1.440897 ESSA shares for each Realm ADS).
Date: August 05, 2019
Source: Seeking Alpha
